Hexagon Capital Partners’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6
| Closed | -$235 | – | 1951 |
|
|
2024
Q4 | $235 | Buy |
+6
| New | +$235 | ﹤0.01% | 1757 |
|
|
2023
Q4 | – | Sell |
-10
| Closed | -$342 | – | 1520 |
|
|
2023
Q3 | $342 | Sell |
10
-72
| -88% | -$2.46K | ﹤0.01% | 1308 |
|
|
2023
Q2 | $3.16K | Hold |
82
| – | – | ﹤0.01% | 994 |
|
|
2023
Q1 | $2.94K | Sell |
82
-27
| -25% | -$966 | ﹤0.01% | 986 |
|
|
2022
Q4 | $4.3K | Sell |
109
-88
| -45% | -$3.47K | ﹤0.01% | 942 |
|
|
2022
Q3 | $7K | Buy |
+197
| New | +$7K | ﹤0.01% | 868 |
|